Cellular models to investigate biochemical pathways in Parkinson's disease
about
Modeling nigrostriatal degeneration in organotypic cultures, a new ex vivo model of Parkinson's diseaseHow the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenarioEarly mitochondrial dysfunction leads to altered redox chemistry underlying pathogenesis of TPI deficiency.Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.Brain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson's disease.The Molecular Chaperone GRP78/BiP as a Therapeutic Target for Neurodegenerative Disorders: A Mini Review.Phenotypic screens targeting neurodegenerative diseases.New insights on the mitochondrial proteome plasticity in Parkinson's disease.Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis.Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells.Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells.Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.Proteomic studies associated with Parkinson's disease.Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death.Interferon Gamma potentiates the injury caused by MPP(+) on SH-SY5Y cells, which is attenuated by the nitric oxide synthases inhibition.Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.Discovery of the neuroprotective effects of alvespimycin by computational prioritization of potential anti-Parkinson agents.Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress.A systems biology-led insight into the role of the proteome in neurodegenerative diseases.Quercetin-mediated synthesis of graphene oxide-silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma.Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.Using Cultured Mammalian Neurons to Study Cellular Processes and Neurodegeneration: A Suite of Undergraduate Lab Exercises.Systems biology analysis of the proteomic alterations induced by MPP(+), a Parkinson's disease-related mitochondrial toxin.Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease.Profiling of Human Molecular Pathways Affected by Retrotransposons at the Level of Regulation by Transcription Factor Proteins.Dopamine induces mitochondrial depolarization without activating PINK1-mediated mitophagy.Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease.Experimental setup for the identification of mitochondrial protease substrates by shotgun and top-down proteomics.Polymeric scaffolds for three-dimensional culture of nerve cells: a model of peripheral nerve regeneration.The Role of Gene Editing in Neurodegenerative Diseases.Current Screening Methodologies in Drug Discovery for Selected Human Diseases
P2860
Q33924432-C6AB11A3-EFB2-41F1-9604-BD4A29916EDBQ35569964-9E6F0208-F2B0-4252-A231-A01CBE22881CQ36773904-47FE29C2-4E6D-4770-A88A-C6AB618334E8Q37105161-F8289873-095A-4639-A5C7-862D183707CAQ37982151-28673673-45B5-4A3E-AC9C-1BE9D8B816D9Q38113221-85C87615-6FE4-4EA0-8ED7-B872FEE4103FQ38130052-02F2374A-724F-4B9A-B18F-8C068F08DE53Q38452561-20F3A361-4D00-4DF4-9F09-C0628DBF4B33Q38478383-BB66212A-D944-425F-9D93-764EB0794DD3Q38684428-D189640A-52F3-4DF0-A0F4-09D2CEE866C1Q38713790-FEB774AE-2CE3-4E22-BF1F-309E671B54A0Q38757787-CBFAC37B-6140-4D63-A865-16BC71FF48B3Q38758318-32A987F1-44DD-4C15-8C91-462287E199E1Q38761409-0DA4EF0A-2996-4A20-A923-0B8C9DCE6124Q38798567-6EF15931-7FD5-467D-8E6E-8A12CB1C72A9Q38949649-74930708-8B28-4DC0-8096-E87DA876CC07Q38978672-FBF29A12-C75B-406F-AF86-7186FFFDD740Q39048969-9B6B2665-26AD-45F1-BC81-768898BC8FA2Q39257810-7CA7B078-C6F9-4DD8-91F2-1060B55E5D10Q39540210-910687F7-A6F9-4C4F-8595-3BCFBC63EDD9Q40071681-66E49E44-C30F-4DE9-8FEC-11B20C7E4362Q41533962-2721A629-BF98-46D3-8C44-68873B14B529Q41851569-6AE2DD3E-07D2-4219-A6B7-345FBAEF5745Q43126583-A5C29929-E217-47F4-AE31-5BE9CA5FE692Q48434410-4580E351-CF9A-4D59-9098-D0A914DEE922Q49307233-F5400E75-0C72-4413-AAA4-CDC12AE998E8Q52892369-7F379EE3-4E4F-4A60-AA3D-D8DDAB6ABC92Q54976661-EA0E2783-B1C5-4EDA-A92C-DA19BF23B731Q55120473-809D0A98-F93B-4431-B980-207EFE361AEEQ55366518-54FE6CF2-5856-4914-9CB9-FD1017B7B7D3Q55709239-8227901B-43BA-40E1-BC3B-9D626198A97CQ57169512-AC58B2F7-4D0A-4474-A6F0-7E9FF421C40D
P2860
Cellular models to investigate biochemical pathways in Parkinson's disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cellular models to investigate biochemical pathways in Parkinson's disease
@ast
Cellular models to investigate biochemical pathways in Parkinson's disease
@en
Cellular models to investigate biochemical pathways in Parkinson's disease
@nl
type
label
Cellular models to investigate biochemical pathways in Parkinson's disease
@ast
Cellular models to investigate biochemical pathways in Parkinson's disease
@en
Cellular models to investigate biochemical pathways in Parkinson's disease
@nl
prefLabel
Cellular models to investigate biochemical pathways in Parkinson's disease
@ast
Cellular models to investigate biochemical pathways in Parkinson's disease
@en
Cellular models to investigate biochemical pathways in Parkinson's disease
@nl
P2860
P1433
P1476
Cellular models to investigate biochemical pathways in Parkinson's disease
@en
P2093
Leonardo Lopiano
P2860
P304
P356
10.1111/J.1742-4658.2012.08516.X
P407
P577
2012-02-28T00:00:00Z